search innovation
keywords: tomography, oncology, cardiology, neurology, monitoring, therapy,
offer number: PET
PET is the tomographic technique widely used in oncology, cardiology and neurology. It plays a fundamental and unique role in diagnostics of the early cancer stages as well as in monitoring therapy results.
The key technology competitive advantages:
Inexpensive scintillation materials- considerably lower cost of detection system.
Reduction of the number of the photomultipliers, while improving the precision of the reconstructed image.
High accuracy measurement of arrival time of pulses with an accuracy of tens of picoseconds.
• The possibility of increasing the size of the diagnostic chamber- imaging of whole human body at the same time.
• The ability of combining with other imaging techniques such as computed tomography and magnetic resonance imaging .
Noninvasive examination of the tissue structure at the atomic level and the ability to estimate the degree of disorders of cell metabolism.
Continuous recording of data acquired during PET imaging allows for lossless saving of virtually all events.
The subject of the offer is new J-PET tomography. The technology was developed by a group of scientist from the Faculty of Physics, Astronomy and Applied Computer Science of the Jagiellonian University in Krakow. The new medical device is based on 14 inventions. Patents were granted in 11 countries. Presented prototype is on TRL4 development level, which cost 1.4M EURO so far.
The group has already successfully build the prototype, which is on TRL 4 development level. Currently group’s research in this area focuses on the construction of the next prototype ready to clinical trials. Moreover, the key and strategic is permission for conducting the clinical trials in Bronowice Cyclotron Center. The huge success is working prototype with parameters: 80 cm- chamber diameter and 50cm- chamber width. Current spatial resolution of image reconstruction reaches accuracy of the up-to-date commercial PET scanners.
Team leader:
Key person in team is inventor of all patents related to New J-PET tomography scanner, Professor Paweł Moskal. He is nuclear and particle physicist and author of over 200 scientific publications and reports. The main areas of professor’s interests are nuclear and particle physics and its application in medicine. He is the Deputy Coordinator of WASA-at-COSY Collaboration, COSY-11 experiment coordinator and also a member of the CERN Scientific Committee. He coordinated the project financed by National Center  for Research and Development under the program  InnoTech for  over $1 M. The prototype is result of this project.
Proposed investment
The group is interested in establishing cooperation with an investor who will bring  €2.5 M in exchange for a stake in the research results and the commercialization benefits. The funds will be allocated to the further technology development from TRL4 to TRL7.
Prof. Paweł Moskal describes his research which shows promise to create higher resolution full-body medical imaging instruments that would be more affordable for developing countries than current technologies.
commercial utility:
The molecular imaging equipment market is comprised of two fairly mature market segments: Nuclear medicine, mainly single-photon emission computed tomography (SPECT), and positron emission tomography (PET) systems. The PET market represents more than 60% of the total revenue opportunity from nuclear medicine market in 2013. The global market valued at $1,533.9M in 2012. The nuclear medicine and PET imaging system market draws almost half of revenues from North America and Europe. Those markets represents 28.7% (443.5M) and 20% ($309.4M) of global market revenues in 2012, respectively. The maximum market potential, calculated as cumulative market revenue from 2013 to 2019, is valued at $3.13 Billion. PET imaging market still hold considerable unexploited potential, especially hybrid PET systems are promising.
field of science:
forms of protection: patent
technological maturity: prototype, demanding R & D
property rights: co-ownership
variants of cooperation: license, consulting, spin-off company, comercial contract research, sale

information / broker of Jagiellonian University

name and surname: Katarzyna Małek-Ziętek
phone number: +48 12 664 42 15, + 48 519 307 961
latest information
JU scientists to develop biological agricultural support solutions
The project “Interactions between plants and microorganisms in response to the presence of potentially toxic metals, metalloids and silicon (Si)” by Prof. Katarzyna Turnau from the JU Faculty of Biology won a grant from the Polish National Agency for Academic Exchange. The study aimed at replacing the widespread use of agrochemicals with biological agricultural support solutions will also involve researchers from Slovakia and Austria.
JU students will help people suffering from depression
Therapify is a mobile application designed to help depressed people. It was first conceived by Łukasz Pstrong, a graduate of the AGH University of Science and Technology in Kraków, and developed over the course of the last two years with collaborators from his university, the Jagiellonian University, and SWPS University of Social Sciences and Humanities in Warsaw.
Plakaty Demo Day II +
In January, we complete the project managed by CTT CITTRU as part of the program of the Ministry of Science and Higher Education - Incubator of Innovation +. We supported, among others, 18 research teams selected in the competition, that develop innovative technologies. Thanks to the funds granted by CTT CITTRU and hard work of technology transfer officers, pre-implementation research was financed, which increased the attractiveness of these inventions and investors interest in them. Take look at the gallery of posters for technologies, developed as part of the project. What do you think about it
Our employees
Innovation Forum KrakówKlaster Lifescience KrakówWolves SummitPACTTJagiellońskie Centrum Innowacji
Centre for Technology Transfer CITTRU
Jagiellonian University in Kraków - POLAND
ul. Bobrzyńskiego 14,
30-348 Kraków

+48 12 664 42 00
Fundusze EuropejskieMNiSWInkubator InnowacyjnościUnia Europejska